The provider prescribes tamoxifen or an aromatase inhibitor to a female patient, 18 years of age or older, with breast cancer. Aromatase is an enzyme that synthesizes estrogen, which is essential for the growth of breast cancer. Tamoxifen inhibits the formation of estrogen and thereby prevents the growth of these cancer cells.
For clinical responsibility, terminology, tips and additional info
start codify free trial.